Brief: Sol-Gel Announces Positive Topline Results From Open-Label, Long-Term Safety Study Of Epsolay® For Treatment Up To 52 Weeks

SOL-GEL TECHNOLOGIES

13/02/2020 21:58

Feb 13 (Reuters) - Sol Gel Technologies Ltd  SLGL.O :
    * SOL-GEL ANNOUNCES POSITIVE TOPLINE RESULTS FROM
OPEN-LABEL,
LONG-TERM SAFETY STUDY OF EPSOLAY® FOR TREATMENT UP TO 52 WEEKS
    * SOL GEL TECHNOLOGIES - NON-CUTANEOUS ADVERSE EVENTS WERE
SIMILAR
IN FREQUENCY AND TYPE TO THOSE OBSERVED IN PRECEDING PHASE 3
TRIALS
    * SOL GEL TECHNOLOGIES LTD - NO SERIOUS DRUG-RELATED ADVERSE
EVENTS WERE REPORTED IN TRIAL

Source text for Eikon:  ID:nGNX7Kjys0 
Further company coverage:  SLGL.O 

 ((Reuters.Briefs@thomsonreuters.com;))